CVS Topical Analgesic Hemorrhoidal
NDC 51316-207, DIBUCAINE, ointment, from CVS PHARMACY,INC.
- Product NDC
- 51316-207
- Status
- Listed
- Labeler
- CVS PHARMACY,INC
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M015
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51316-207 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIBUCAINE10 mg/mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51316-207-28 | 51316020728 | 28 mL in 1 TUBE (51316-207-28) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 51316-207 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51316-207 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51316-207. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.